on SWK Holdings Corp.
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
SWK Holdings Corporation (NASDAQ:SWKH), a specialty finance company focused on life sciences, announced several corporate and borrower portfolio achievements. The company advanced capital to two existing borrowers during Q2 2024 and is planning an additional closing soon. New CFO Adam Rice joined in July, and Courtney Baker was promoted to Controller in June. SWK repurchased $1 million of stock during Q2 and a total of $3.4 million year-to-date.
New financings included $2 million to AOTI, Inc. in May and $5 million to Journey Medical Corporation in June. Noteworthy portfolio updates: AOTI raised £35.1 million through an IPO on the London Stock Exchange, Biolase broadened its customer base, Biotricity increased revenue by 25%, Elutia reported 28% sales growth, and Eton Pharmaceuticals saw a 50% revenue increase.
Journey Medical Corporation's revenue grew by 7% for Q1 2024, and Shield Therapeutics plc reported a 174% increase in Accrufer® prescriptions for Q1 2024.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SWK Holdings Corp. news